Avia Latrelle Reaves, FNP-BC | |
1301 Taylor St Ste 8a, Columbia, SC 29201 | |
(803) 929-2955 | |
Not Available |
Full Name | Avia Latrelle Reaves |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 5 Years |
Location | 1301 Taylor St Ste 8a, Columbia, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164076733 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 23110 (South Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Prisma Health Baptist | Columbia, SC | Hospital |
Prisma Health Richland Hospital | Columbia, SC | Hospital |
Prisma Health Baptist Parkridge | Columbia, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Prisma Health Medical Group-midlands | 5991099707 | 865 |
News Archive
In time for the chocolate-giving and chocolate-noshing fest on Valentine's Day, scientists are reporting discovery of how this treat boosts the body's production of high-density lipoprotein cholesterol (HDL) - the "good" form of cholesterol that protects against heart disease.
Abbott and AstraZeneca confirmed they will advance the development of Abbott's next-generation fenofibrate ABT-335 and AstraZeneca's CRESTOR (rosuvastatin calcium) in a fixed-dose combination treatment into Phase III clinical trials.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Limit values for fine dust emissions are based on total particle weight. It is the ultra-fine particles, however, that are particularly harmful to health. A new technique separates them by size and identifies their composition - directly where they arise.
› Verified 7 days ago
Entity Name | Prisma Health Medical Group-midlands |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275988321 PECOS PAC ID: 5991099707 Enrollment ID: O20160802001226 |
News Archive
In time for the chocolate-giving and chocolate-noshing fest on Valentine's Day, scientists are reporting discovery of how this treat boosts the body's production of high-density lipoprotein cholesterol (HDL) - the "good" form of cholesterol that protects against heart disease.
Abbott and AstraZeneca confirmed they will advance the development of Abbott's next-generation fenofibrate ABT-335 and AstraZeneca's CRESTOR (rosuvastatin calcium) in a fixed-dose combination treatment into Phase III clinical trials.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Limit values for fine dust emissions are based on total particle weight. It is the ultra-fine particles, however, that are particularly harmful to health. A new technique separates them by size and identifies their composition - directly where they arise.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Avia Latrelle Reaves, FNP-BC 1301 Taylor St Ste 8a, Columbia, SC 29201-2955 Ph: (803) 929-2955 | Avia Latrelle Reaves, FNP-BC 1301 Taylor St Ste 8a, Columbia, SC 29201 Ph: (803) 929-2955 |
News Archive
In time for the chocolate-giving and chocolate-noshing fest on Valentine's Day, scientists are reporting discovery of how this treat boosts the body's production of high-density lipoprotein cholesterol (HDL) - the "good" form of cholesterol that protects against heart disease.
Abbott and AstraZeneca confirmed they will advance the development of Abbott's next-generation fenofibrate ABT-335 and AstraZeneca's CRESTOR (rosuvastatin calcium) in a fixed-dose combination treatment into Phase III clinical trials.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Limit values for fine dust emissions are based on total particle weight. It is the ultra-fine particles, however, that are particularly harmful to health. A new technique separates them by size and identifies their composition - directly where they arise.
› Verified 7 days ago
Mr. Joseph Crawford Iii, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Richland Medical Park Dr Ste 300, Columbia, SC 29203 Phone: 803-256-6511 | |
Richard Hall Iii, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Richland Medical Park Dr Ste 100, Columbia, SC 29203 Phone: 803-434-6095 Fax: 803-758-0120 | |
Latonya Brailsford, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4605 Monticello Rd Ste 2, Columbia, SC 29203 Phone: 803-753-5590 Fax: 803-753-5592 | |
Laketa D Riley, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Doctor Cir, Columbia, SC 29203 Phone: 800-491-0909 | |
Jenny O'neill, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 Arbor Lake Dr, Suite 120, Columbia, SC 29223 Phone: 803-457-8125 Fax: 803-457-8129 | |
Sarah Elizabeth Wilson, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9 Richland Medical Park Dr Ste 420, Columbia, SC 29203 Phone: 803-434-3950 Fax: 803-434-3496 | |
Miss Karen Mccain, NURSE PRACTITONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Doctor Cir, Columbia, SC 29203 Phone: 800-491-0909 |